Irizarry Karina, Rossbach Hans Christof, Ignacio Joseph R A, Winesett Michele P, Kaiser Greg C, Kumar Mudra, Gilbert-Barness Enid, Wilsey Michael J
Department of Pediatrics, University of South Florida College of Medicine, Tampa, Florida, USA.
Pediatr Hematol Oncol. 2006 Mar;23(2):95-102. doi: 10.1080/08880010500456964.
Sickle cell intrahepatic cholestasis (SCIC) is a rare complication seen in sickle cell patients who present with sudden onset of RUQ pain, progressive hepatomegaly, mild elevation of transaminases, coagulopathy, and extreme hyperbilirubinemia. Early recognition of this entity is essential to avoid life-threatening complications. Diagnosis can be challenging given the overlap in clinical presentation with other conditions affecting the hepatobiliary biliary system in sickle cell anemia such as hepatitis, cholecystitis, and hepatic crisis. Treatment is currently limited to exchange transfusion. The authors present two patients with SCIC and cholelithiasis; the clinical picture of one is complicated by choledocholithiasis.
镰状细胞性肝内胆汁淤积症(SCIC)是镰状细胞病患者中罕见的并发症,表现为突发右上腹疼痛、进行性肝肿大、转氨酶轻度升高、凝血功能障碍和极度高胆红素血症。早期识别该病症对于避免危及生命的并发症至关重要。鉴于其临床表现与镰状细胞贫血中影响肝胆系统的其他病症(如肝炎、胆囊炎和肝危象)存在重叠,诊断可能具有挑战性。目前的治疗仅限于换血疗法。作者介绍了两名患有SCIC和胆结石的患者;其中一名患者的临床表现因胆总管结石而复杂化。